The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...

WASHINGTON — Environmental Protection Agency (EPA) Administrator Lee Zeldin announced Wednesday that his agency would renew its commitment to end the testing of chemicals on mammals by 2035. The first ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

South Carolina has become a breeding ground for laboratory animals destined for invasive, painful and often lethal experiments. The state is home to both Morgan Island (known as Monkey Island), where ...